Search results for "Statins"
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, I.M. Matters Weekly from ACP.
https://immattersacp.org/archives/2024/01/latest-updates-on-acps-priorities-initiatives.htm
1 Jan 2024
Statins appear to benefit all ages, may be less helpful for primary prevention in the elderly
A meta-analysis by the Cholesterol Treatment Trialists' Collaboration looked at the effect of statins on major vascular events, cause-specific mortality, and cancer incidence.
https://immattersacp.org/weekly/archives/2019/02/12/4.htm
12 Feb 2019
Rosuvastatin, atorvastatin compared on effectiveness, safety in industry-funded trial
Analysis of a randomized trial in South Korea found that patients randomized to rosuvastatin developed type 2 diabetes requiring medication at a rate of 7.2%, compared to 5.3% among those given atorvastatin.
https://immattersacp.org/weekly/archives/2023/10/24/4.htm
24 Oct 2023
Studies highlight limitations, potential alternatives to common risk equations for CVD
Removing race from the pooled cohort risk equations for cardiovascular disease (CVD) did not affect accuracy, according to results of a recent study, while another tested a prediction model based only on sex, age, and routine lab tests.
https://immattersacp.org/weekly/archives/2023/12/12/1.htm
12 Dec 2023
The never-ending push-pull of statins
Statins have proven their potential to reduce end-point outcomes, such as death from cardiovascular disease. But the drug class also has some downsides, and the pros and the cons become a close call.
https://immattersacp.org/archives/2017/04/statins.htm
1 Apr 2017
Statins often not prescribed in younger patients with dyslipidemia, study finds
Patients who had at least one indication for statin therapy were analyzed according to the following groups: LDL cholesterol level of at least 190 mg/dL, diabetes and LDL cholesterol level above 70 mg/dL, and atherosclerotic cardiovascular disease.
https://immattersacp.org/weekly/archives/2017/01/10/2.htm
10 Jan 2017
Cardiology societies update guideline on management of chronic coronary disease
The guideline from the American Heart Association and the American College of Cardiology emphasizes coordinating care between cardiovascular and primary care professionals and prioritizing symptom relief and quality of life, among other recommendations.
https://immattersacp.org/weekly/archives/2023/08/01/2.htm
1 Aug 2023
Guidance issued on drug-drug interactions for statins, heart meds
A new statement from the American Heart Association recommends that in patients taking amlodipine combined with simvastatin or lovastatin, the dosage of either statin should not exceed 20 mg/d, and for patients in whom statin-fibrate therapy is indicated, fenofibrate or fenofibric acid is preferred because of a lower rate of drug-drug interactions.
https://immattersacp.org/weekly/archives/2016/10/25/2.htm
25 Oct 2016
Studies, CMS look at lowering prescription prices
Even as Medicare seeks to negotiate down the costs of 10 prescription drugs, researchers are examining the effectiveness of existing private programs to provide lower drug costs and copays.
https://immattersacp.org/weekly/archives/2023/09/05/1.htm
5 Sep 2023
Statins may be significantly overprescribed for primary prevention, computer model suggests
An analysis compared risk of drug-related events, including myopathy, hepatic dysfunction, and incident diabetes, to predicted cardiovascular benefit for men and women at various ages.
https://immattersacp.org/weekly/archives/2018/12/04/1.htm
4 Dec 2018